Transgenic aves producing human polyclonal antibodies
AssigneeSynageva BioPharma Corp.
InventorsRobert J. Etches, Robert M. Kay, Philip Leighton, Lei Zhu
Life of this patent
Estimating the term…
Loading patent…
AssigneeSynageva BioPharma Corp.
InventorsRobert J. Etches, Robert M. Kay, Philip Leighton, Lei Zhu
Estimating the term…
Human antibodies are produced in transgenic chickens having functional genetic components of the human immune system stably integrated in the genome. Techniques are described to integrate unrearranged human heavy and light chain immunoglobulin loci into the genome of the transgenic chicken. The functional description of the endogenous immunoglobulin loci yields an animal whose antibody repertoire in response to antigen is fully human. In the preferred embodiment, the human immunoglobulin locus is at least as large as the native human locus and exhibits functional class switching to yield IgG isotype antibodies. In addition to monoclonal antibodies secreted from immortalized B cell populations, polyclonal antibodies may be obtained from eggs laid by the transgenic chickens of the invention.
-20. (canceled)
An isolated human polyclonal antibody obtained from a transgenic chicken in response to antigen stimulation, wherein the transgenic chicken has a functional disruption of an endogenous chicken immunoglobulin heavy chain and light chain gene and comprising a transgene comprising a nucleic acid molecule encoding a human immunoglobulin heavy chain and a human immunoglobulin light chain.
Dependencies are inferred from the claim text.